SANSURE BIOTECH INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.6 CNY | -1.01% |
|
+0.68% | +5.37% |
| 04-26 | Sansure Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 02-29 | Sansure Biotech's 2023 Profit Drops 81% as Revenue Slumps 84% | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Diagnostic & Testing Substances
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 1.64B | - | - | - | - | - | |
| 12.64B | ||||||
| 8.46B | ||||||
| 5.27B | - | - | ||||
| 4.49B | ||||||
| 3.11B | - |
